
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 20, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 20, 2024
Language: Английский
Epigenomics, Journal Year: 2025, Volume and Issue: 17(2), P. 125 - 140
Published: Jan. 19, 2025
Gliomas, highly aggressive tumors of the central nervous system, present overwhelming challenges due to their heterogeneity and therapeutic resistance. Glioblastoma multiforme (GBM), most malignant form, underscores this clinical urgency dismal prognosis despite treatment regimens. Recent advances in cancer research revealed signaling pathways epigenetic mechanisms that intricately govern glioma progression, offering multifaceted targets for intervention. This review explores dynamic interplay between events regulation context glioma, with a particular focus on crucial roles played by non-coding RNAs (ncRNAs). Through direct indirect targeting, ncRNAs emerge as key regulators shaping molecular landscape glioblastoma across its various stages. By dissecting these intricate regulatory networks, novel patient-tailored strategies could be devised improve patient outcomes devastating disease.
Language: Английский
Citations
0Cellular and Molecular Neurobiology, Journal Year: 2025, Volume and Issue: 45(1)
Published: Feb. 9, 2025
Language: Английский
Citations
0Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: June 10, 2024
Brain tumors and genomics have a long-standing history given that glioblastoma was the first cancer studied by genome atlas. The numerous continuous advances through decades in sequencing technologies aided advanced molecular characterization of brain for diagnosis, prognosis, treatment. Since implementation biomarkers WHO CNS 2016, has been integrated into diagnostic criteria. Long-read sequencing, also known as third generation is an emerging technique allows longer DNA segments leading to improved detection structural variants epigenetics. These capabilities are opening way better tumors. Here, we present comprehensive summary state art third-generation application tumor We discuss advantages potential new implementations long-read clinical paradigms neuro-oncology patients.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 20, 2024
Language: Английский
Citations
0